Structure-based design of Trifarotene, a potent and selective RAR agonist for the treatment of acne

导出原文传递

翻译打印收藏纠错

作者： Thoreau, E. ^[1] ; Arlabosse, J. ^[2] ; Bouix-peter, C. ^[3] ; Chambon, S. ^[4] ; Chantalat, L. ^[5] ; Daver, S. ^[6] ; Dumais, L. ; Duvert, G. ; Feret, A. ; Ouvry, G. ; Pascau, J. ; Raffin, C. ; Rodeville, N. ; Soulet, C. ; Tabet, S. ; Talano, S. ; Portal, T.

作者单位： Nestle Skin Hlth, New York, NY USA ^[1] Virbac, Carros, France ^[2] Nestle Skin Hlth, Biot, France ^[3] Galderma R&D, Biot, France ^[4] Galderma SA, Lausanne, Switzerland ^[5] Galderma R&D, Nestle Skin Hlth, Biot, France ^[6]

发布时间 2020-09-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

The Journal of investigative dermatology.

2018年138卷9期

B17-B17页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Structure-based design of Trifarotene, a potent and selective RAR agonist for the treatment of acne

The Journal of investigative dermatology.

相似文献

The Journal of investigative dermatology.

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Structure-based design of Trifarotene, a potent and selective RAR agonist for the treatment of acne

The Journal of investigative dermatology.

相似文献

The Journal of investigative dermatology.

相关期刊

检索历史清除